Cencora, Inc. (COR)
(Delayed Data from NYSE)
$225.35 USD
-2.98 (-1.31%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $225.41 +0.06 (0.03%) 4:42 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
COR 225.35 -2.98(-1.31%)
Will COR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for COR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for COR
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
COR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Other News for COR
Goldman rebalances low labor cost basket amid cooling labor market
May 2025 Options Now Available For Cencora (COR)
Cencora cut to Neutral at BofA; risks to Walgreens, Cigna contracts cited
COR Crosses Below Key Moving Average Level
Nvidia, ARM initiated: Wall Street's top analyst calls